Insights on the Closed System Transfer Devices Global Market to 2027 - Featuring Caragen, Cardinal Health and JMS Among Others - ResearchAndMarkets.com

The "Closed System Transfer Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, July 29, 2021
Information
Tags: 
Health, Other Health, Draft:ByteBridge.io
Geotags: 
JAPAN, US, EUROPE, CHINA, CANADA, GERMANY
⚠generated by AI ↴
Summary
Key Points: 
  • The "Closed System Transfer Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Closed System Transfer Devices estimated at US$457 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 19.4% over the period 2020-2027.
  • Membrane-to-Membrane Systems, one of the segments analyzed in the report, is projected to record 19.9% CAGR and reach US$1 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $122.8 Million, While China is Forecast to Grow at 24.7% CAGR
    The Closed System Transfer Devices market in the U.S. is estimated at US$122.8 Million in the year 2020.


The "Closed System Transfer Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Closed System Transfer Devices estimated at US$457 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 19.4% over the period 2020-2027.

Membrane-to-Membrane Systems, one of the segments analyzed in the report, is projected to record 19.9% CAGR and reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Needleless Systems segment is readjusted to a revised 18.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $122.8 Million, While China is Forecast to Grow at 24.7% CAGR

The Closed System Transfer Devices market in the U.S. is estimated at US$122.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$381.9 Million by the year 2027 trailing a CAGR of 24.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14% and 17.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.3% CAGR.

Select Competitors (Total 42 Featured):

  • B. Braun Melsungen
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Caragen Ltd.
  • Cardinal Health
  • Carmel Pharma, Inc
  • Codan Medizinische Gerate GmbH & Co Kg
  • Corvida Medical
  • Equashield LLC.
  • Hospira (acquired by Pfizer)
  • ICU Medical, Inc.
  • JMS Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Victus, Inc.
  • Yukon Medical

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/n8s5bk

Copyright: 
Copyright Business Wire 2021